149 related articles for article (PubMed ID: 9281835)
21. Antimicrobial activity of cefoperazone with clavulanic acid or sulbactam against Enterobacteriaceae.
Nagy E; Hajdu E; Földes J
J Antimicrob Chemother; 1990 Apr; 25(4):701-3. PubMed ID: 2351631
[No Abstract] [Full Text] [Related]
22. [The development of bacterial resistance and the role of clavulanic acid].
Rolinson JN
Antibiot Khimioter; 1992 Sep; 37(9):11-4. PubMed ID: 1444658
[No Abstract] [Full Text] [Related]
23. In-vitro susceptibility of Xanthomonas maltophilia to aztreonam and clavulanic acid as a test for the presumptive identification of the species.
Townsend R; Winstanley TG; Spencer RC
J Hosp Infect; 1991 Aug; 18(4):324-5. PubMed ID: 1682373
[No Abstract] [Full Text] [Related]
24. Potential effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid on human granulocyte activity: a comparative study.
Cuffini AM; Tullio V; Paizis G; Carlone NA
J Antimicrob Chemother; 1996 Dec; 38(6):1013-22. PubMed ID: 9023648
[TBL] [Abstract][Full Text] [Related]
25. In-vitro pharmacodynamic simulation of clavulanic acid concentrations: effect on Staphylococcus aureus and Haemophilus influenzae beta-lactamase activity.
Martín M; Aguilar L; Balcabao IP; Gómez-Lus ML; Dal-Ré R; Prieto J
J Antimicrob Chemother; 1997 Feb; 39(2):290-2. PubMed ID: 9069559
[No Abstract] [Full Text] [Related]
26. Increased beta-lactamase activity in Branhamella catarrhalis after exposure to amoxicillin and clavulanic acid.
Bedenić B; Zagar Z
J Chemother; 1994 Dec; 6(6):383-7. PubMed ID: 7699424
[TBL] [Abstract][Full Text] [Related]
27. Use of amikacin and amoxicillin-clavulanic acid against Mycobacterium tuberculosis.
Tamás F
Chest; 1993 Jul; 104(1):328. PubMed ID: 8325113
[No Abstract] [Full Text] [Related]
28. [Synergistic effect of new beta-lactam antibiotics, clavulanic acid and dibekacin on pathogenic microorganisms].
Jastalska D; Lupicki W; Zapaśnik M; Pajchel G; Chojnowski W
Pol Tyg Lek; 1984 Oct; 39(43):1415-8. PubMed ID: 6440130
[No Abstract] [Full Text] [Related]
29. In-vitro activity of amoxycillin/clavulanic acid and five other oral antibiotics against clinical isolates of Haemophilus influenzae and Branhamella catarrhalis.
Fernández-Roblas R; Jiménez Arriero M; Rodriguez-Tudela JL; Soriano F
J Antimicrob Chemother; 1988 Dec; 22(6):867-72. PubMed ID: 3149634
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous determination of the binary mixtures of cefsulodin and clavulanic acid by using first-derivative spectrophotometry.
Murillo JA; Lemus JM; García LF
J Pharm Biomed Anal; 1995 May; 13(6):769-76. PubMed ID: 7669831
[TBL] [Abstract][Full Text] [Related]
31. Comparative activity in vitro of ticarcillin and ticarcillin plus clavulanic acid against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter calcoaceticus.
Campos P; Vera A; Martin-Luengo F
Chemioterapia; 1987 Jun; 6(2 Suppl):77-8. PubMed ID: 3151358
[No Abstract] [Full Text] [Related]
32. The in-vitro susceptibility of the Bacteroides fragilis group to amoxycillin-clavulanic acid.
Brown EM
J Antimicrob Chemother; 1984 Oct; 14(4):367-72. PubMed ID: 6501130
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers.
Barry AL; Ayers LW; Gavan TL; Gerlach EH; Jones RN
Eur J Clin Microbiol; 1984 Jun; 3(3):203-6. PubMed ID: 6147246
[TBL] [Abstract][Full Text] [Related]
34. Beta-lactam/beta-lactamase inhibitor combinations: development, antibacterial activity and clinical applications.
Sutherland R
Infection; 1995; 23(4):191-200. PubMed ID: 8522374
[No Abstract] [Full Text] [Related]
35. Biosynthesis and molecular genetics of clavulanic acid.
Jensen SE; Paradkar AS
Antonie Van Leeuwenhoek; 1999; 75(1-2):125-33. PubMed ID: 10422585
[TBL] [Abstract][Full Text] [Related]
36. Comparative in vitro susceptibilities of 504 bacteremic isolates to ticarcillin plus clavulanic acid and other antimicrobial agents.
Rotstein C; Amsterdam D; Beam T; Gorzynski E
Diagn Microbiol Infect Dis; 1989; 12(2):157-63. PubMed ID: 2752713
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the Streptomyces clavuligerus argC gene encoding N-acetylglutamyl-phosphate reductase: expression in Streptomyces lividans and effect on clavulanic acid production.
Ludovice M; Martin JF; Carrachas P; Liras P
J Bacteriol; 1992 Jul; 174(14):4606-13. PubMed ID: 1339424
[TBL] [Abstract][Full Text] [Related]
38. Structure-chiroptical properties relationship in clavams: an experimental and theoretical study.
Chmielewski M; Cierpucha M; Kowalska P; Kwit M; Frelek J
Chirality; 2008 May; 20(5):621-7. PubMed ID: 17924419
[TBL] [Abstract][Full Text] [Related]
39. Intracellular and extracellular killing of a penicillin-resistant, serotype-9 strain of Streptococcus pneumoniae by polymorphonuclear leucocytes in the presence of sub-inhibitory concentrations of clavulanic acid.
Gómez-Lus ML; Aguilar L; Martín M; Giménez MJ; Martínez P; Prieto J
J Antimicrob Chemother; 1997 Jul; 40(1):142-4. PubMed ID: 9249222
[No Abstract] [Full Text] [Related]
40. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
Grace ME; Fu KP; Gregory FJ; Hung PP
Drugs Exp Clin Res; 1987; 13(3):145-8. PubMed ID: 3040368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
